AR-R17779

Izvor: Wikipedia
AR-R17779
AR-R17779 structure.png
IUPAC ime
Identifikacija
CAS registarski broj 178419-47-1 YesY
PubChem[1][2] 5310971
ChemSpider[3] 4470515 YesY
ChEBI CHEBI:420311
ChEMBL[4] CHEMBL193016 YesY
Jmol-3D slike Slika 1
Svojstva
Molekulska formula C9H14N2O2
Molarna masa 182.22 g mol−1

 YesY (šta je ovo?)   (verifikuj)

Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje (25 °C, 100 kPa) materijala

Infobox references

AR-R17779 je lek koji deluje kao potentan i selektivan pun agonist za α7 podtip neurskih nikotinskih acetilholinskih receptora.[5][6] On ispoljava nootropne efekte u životinjskim studijama,[7][8] mada ta dejstva ne zamenjuju dejstva nikotina.[9] On je nedavno izučavan kao potentan nov tretman za artritis.[10]

Reference[uredi - уреди]

  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). "PubChem as a public resource for drug discovery.". Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). "Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities". Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). "Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining". J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). "ChEMBL: a large-scale bioactivity database for drug discovery". Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  5. (2000) "(-)-Spiro1-azabicyclo2.2.2octane-3,5'-oxazolidin-2'-one, a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor". Journal of Medicinal Chemistry 43 (22): 4045–4050. DOI:10.1021/jm000249r. PMID 11063601. 
  6. (2004) "A chiral synthesis of (-)-spiro1-azabicyclo2.2.2octane-3,5'- oxazolidin-2'-one: a conformationally restricted analogue of acetylcholine that is a potent and selective alpha7 nicotinic receptor agonist". The Journal of Organic Chemistry 69 (19): 6493–6495. DOI:10.1021/jo049404q. PMID 15357617. 
  7. (1999) "AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats". Behavioural Pharmacology 10 (6–7): 675–680. DOI:10.1097/00008877-199911000-00014. PMID 10780509. 
  8. (2004) "AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors". Psychopharmacology 172 (4): 375–383. DOI:10.1007/s00213-003-1668-7. PMID 14727003. 
  9. (2000) "Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine". The Journal of Pharmacology and Experimental Therapeutics 294 (3): 1112–1119. PMID 10945867. 
  10. (2009) "Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice". Arthritis and rheumatism 60 (1): 114–122. DOI:10.1002/art.24177. PMID 19116908. 

Spoljašnje veze[uredi - уреди]